An interventional study of NIC Psychotherapeutic Intervention(s) for Anxiety and Psychopharmaceuticals (any drugs prescribed by the psychiatrist) in Anxiety, sponsored by Francisco Miguel Correia Sampaio. Completed. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2017-05-16.
Sponsored by Francisco Miguel Correia Sampaio · Not applicable, Interventional, and Treatment
This study aims to evaluate the efficacy of a psychotherapeutic intervention model in nursing on the nursing diagnosis "Anxiety". A randomised controlled trial will be carried out to do so.
This study aims to evaluate the efficacy of a psychotherapeutic intervention model in nursing on nursing diagnosis "Anxiety" (according to International Classification for Nursing Practice (ICNP)/North American Nursing Diagnoses Association (NANDA) standardized nursing language). A randomised controlled trial will be carried out to do so. In a single-blinded nurse-led 6 months controlled trial, conducted at a hospital outpatient setting in Portugal, approximately 60 patients with anxiety will be randomised to the intervention (n=30) or control groups (n=30). The objective is to compare the outcomes associated with "treatment-as-usual" and the benefits of implementing the psychotherapeutic intervention model in nursing previously developed (5 sessions), which will be evaluated using Nursing Outcomes Classification (NOC) outcomes "Anxiety Level" and "Anxiety Self-Control" (Portuguese version).
4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.
This study's enrollment of 133 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →This is the only study on the registry with Francisco Miguel Correia Sampaio as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
People diagnosed with "Anxiety" (according to ICNP/NANDA standardized nursing language) will be treated using Nursing Interventions Classification (NIC) psychotherapeutic intervention(s) for anxiety (plus psychopharmaceuticals).
Behavioral: NIC Psychotherapeutic Intervention(s) for Anxiety · Drug: Psychopharmaceuticals (any drugs prescribed by the psychiatrist)
People diagnosed with "Anxiety" (according to ICNP/NANDA standardized nursing language) will receive treatment as usual for anxiety (psychopharmaceuticals).
Drug: Psychopharmaceuticals (any drugs prescribed by the psychiatrist)
Patients will be treated by NIC psychotherapeutic intervention(s) for anxiety (e.g. anxiety reduction) plus psychopharmaceuticals prescribed by their psychiatrist.
Patients will be treated only by psychopharmaceuticals prescribed by their psychiatrist.
Change in the Level of Anxiety (NOC outcomes "Anxiety Level" and "Anxiety Self-Control" - Portuguese version)
Time frame: At the beginning of the study (Session 0) and one week after session 5 (approximately 6 weeks after the beginning of the study)
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.